Physicians Formula (FACE) Stock Price, News & Analysis

Company Overview

Physicians Formula Holdings, Inc. is a United States-based company that manufactures and distributes mass color cosmetics. The Company focuses in color correction and brings department store concepts to the mass market. Its products focus on addressing skin imperfections through a problem-solution approach. Its products address specific, everyday cosmetics needs and include face powders, bronzers, concealers, blushes, foundations, eye shadows, eye liners, brow makeup and mascaras. The Company sells its products in the mass market channel to retailers.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 120 shs
• Average Volume: 78,600 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FACE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Physicians Formula own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Physicians Formula investors own include PayPal (PYPL), Synchronoss Technologies (SNCR), Mesabi Trust (MSB), CocaCola (KO), Isracann Biosciences (ISCNF) and Alibaba Group (BABA).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:FACE
• CIK: 1269871
• Web: www.physiciansformula.com
• Phone: +1-626-3343395
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A